When it comes to exercising for heart health, staying active into middle age is crucial. Research indicates that maintaining ...

As the world gears up to celebrate International Day of Yoga 2025, discover how this time-tested wellness practice can help ...

A twice-yearly injection could revolutionize how high blood pressure is treated, offering a major breakthrough for millions ...

A modified DASH diet, tailored for individuals with type 2 diabetes, significantly lowers blood pressure, even for those ...

When it comes to exercising for heart's sake, you don't want to peak too early in life. Research suggests that if you want to ...

High blood pressure, also known as hypertension, is a common health concern that significantly increases the risk of heart ...

Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...

The first participant has been dosed in a Phase 1 trial testing F230 for the treatment of pulmonary arterial hypertension.

Hypertension continues to present as a significant global health challenge, contributing notably to cardiovascular disease morbidity and mortality rates, as ...

Hypertension treatment and the role of cortisol in cardio-renal-metabolic health were among the featured topics from this ...

The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

A spirited pro/con debate at ERA 2025 explores whether population-level albuminuria screening could improve early CKD detection, with feasibility, cost-effectiveness, and equity all weighed.